Hyaluronan Or Derivative, Gelsyn-3, For Intra-Articular Injection, 0.1 Mg in North Carolina
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in North Carolina
| Provider | Medicare | Services |
|---|---|---|
| Mcavoy, Elizabeth PA-C | $0.54 | 82.0K |
| Miller, Jared D.O. | $0.51 | 39.8K |
| Satterfield, Robert MD | $0.59 | 25.2K |
| Hughes, Erin FNP-C | $0.62 | 23.4K |
| Wohlrab, Kurt MD, MPH | $0.52 | 23.0K |
| Ham, Jeffrey DO | $0.56 | 19.5K |
| Smith, Stephen PA-C | $0.66 | 18.8K |
| Castle, Daniel PA-C | $0.51 | 18.6K |
| Burroughs, Kevin MD | $0.52 | 17.8K |
| Eich, Joseph PA-C | $0.53 | 17.5K |
North Carolina Pricing in Context
In North Carolina, CPT code J7328 (Hyaluronan Or Derivative, Gelsyn-3, For Intra-Articular Injection, 0.1 Mg) carries an average Medicare payment of $0.55 — 3% above the national benchmark of $0.54. 278 providers across the state submitted claims for this procedure in 2023, performing 939.4K total services. Individual payments in NC ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in North Carolina is $5.39, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because North Carolina sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Drugs (Administered) procedures, the estimated commercial insurance price in North Carolina lands near $1.57, with self-pay cash prices typically around $2.02. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Hyaluronan Or Derivative, Gelsyn-3, For Intra-Articular Injection, 0.1 Mg cost in North Carolina?
The average Medicare payment for Hyaluronan Or Derivative, Gelsyn-3, For Intra-Articular Injection, 0.1 Mg in North Carolina is $0.55, which is 3% above the national average of $0.54. Providers in NC typically bill $5.39 for this procedure.
What does Hyaluronan Or Derivative, Gelsyn-3, For Intra-Articular Injection, 0.1 Mg cost with insurance in North Carolina?
With commercial insurance in North Carolina, Hyaluronan Or Derivative, Gelsyn-3, For Intra-Articular Injection, 0.1 Mg costs an estimated $1.57. Without insurance, the estimated cash price is $2.02. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Hyaluronan Or Derivative, Gelsyn-3, For Intra-Articular Injection, 0.1 Mg in North Carolina?
278 providers in North Carolina billed Medicare for Hyaluronan Or Derivative, Gelsyn-3, For Intra-Articular Injection, 0.1 Mg in 2023, performing 939.4K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Hyaluronan Or Derivative, Gelsyn-3, For Intra-Articular Injection, 0.1 Mg cheaper in North Carolina than the national average?
No — Hyaluronan Or Derivative, Gelsyn-3, For Intra-Articular Injection, 0.1 Mg costs 3% above the national average in North Carolina. The state average Medicare payment is $0.55 compared to $0.54 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.